2 companies
argenx
Market Cap: €43.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€701.00
7D
1.1%
1Y
36.2%
Solvay
Market Cap: €2.7b
Provides basic and performance chemicals worldwide.
SOLB
€26.00
7D
-0.8%
1Y
-9.2%